Creative Biolabs-Immuno-oncology

Anti-MUC16 (clone OC1F3) SynExpress C-Cy3-P-P Modified CD8+ T cells (CAT#: ITS-1224-CR1256)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target MUC16 (clone OC1F3). We employs the HBV (CMV-Cy3-PAX-PstI) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
MUC16
Clone
OC1F3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
PAX
Insertion Sites
PstI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.98
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving